EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Advancing Biopharmaceutical Innovation Through Cell Encapsulation and Biomimetic Therapeutic Systems
My interest in biopharmaceutical engineering began during my senior year as an undergraduate For my capstone project I worked on the encapsulation of...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
How Pharma Companies Are Building Commercial Strategies for High-Cost Therapies
American medicine has entered an era in which a single treatment can deliver decades of benefit and in some cases a potential cure after one administration Gene therapies for inherited blood disorders engineered cell therapies for cancer and advanced treatments for rare neuromuscular and metabolic diseases are no longer experimental curiosities They are approved reimbursed and reaching patients Th...
-
Techno Trends
Scholar Rock gains FDA approval for ISEMBYLD in SMA
Scholar Rock has received US Food and Drug Administration FDA approval for ISEMBYLD apitegromabmstn for the treatment of spinal
-
Projects
Sandoz to Invest US$300 Million in New Biosimilar Facility in Ljubljana
Sandoz is investing approximately US million in a new biosimilar drug substance manufacturing facility in Ljubljana Slovenia The investment will expand the companys inhouse manufacturing capacity
-
Research Insights
Phycocyanobilin: A potential bioactive compound from Arthrospira platensis targeting LYN protein associated with systemic lupus erythematosus
Phycocyanobilin a bioactive compound derived from Arthrospira platensis C was investigated for its potential role in systemic lupus erythematosus SLE based on its structural similarity to bilirubin
-
White Papers
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys complexity
TOP ARTICLES
-
1
Biosimilars in the U.S.: Unraveling Market Dynamics and Winning B2B Collaboration Strategies
Kate Williamson
This B2B guide delves into the dynamic landscape of biosimilars in the U.S., offering insights into market dynamics and successful collaboration strategies. From understanding regulatory challenges to...
-
2
From Qubits to Proteins: Quantum Computing's Promise in Protein Folding
Vidya Niranjan
Quantum computing's fusion with biochemistry ushers a new era of scientific exploration, offering breakthroughs in pharmaceuticals. This article explores quantum mechanics' role in protein fol...
-
3
Pharmaceutical Compliance and Ethical Practices in the U.S. Market
Kate Williamson
Pharmaceutical compliance in the U.S. protects patients, companies, and public trust. This article explores compliance programs, codes of conduct, and ethical practices shaping the American pharma ind...
-
4
Alzheimer's Drug Pipeline: Past, Present, and Future Biologic Therapies
Ronny Priefer
Chaehui Sue
The history of Alzheimer’s disease treatment has been fraught with numerous failures, with only a smattering of successes. The rationales for failures are as diverse as the agents and targets th...
-
5
The Procedure of Pharmaceutical Development
Xiaoya Zhang
Pharmaceutical development is the identification and evaluation of cycles needs to change over a functioning drug fixing into a medication item reasonable for its expected reason. In the beginning pha...
press releasesRead more...
INFORS HT Launches Multifors 3 bench-top bioreactor for process development
Multifors is what benchscale parallel bioprocessing should look like in Its built around a simple idea the bioreactor should capture and retain the information that matters so scientists can focus
AVS Bio, an Arlington Capital Partners Portfolio Company, Acquires Biorbyt Ltd.
AVS Bio the Company a leading global provider of critical inputs and services for the bioprocessing and biologics industries today announced it has acquired Biorbyt Ltd Biorbyt a global supplier
Abbott And Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health
Abbott and Berry Street today announced an exclusive partnership to help people take a more proactive approach to nutrition and longterm health The partnership brings together Lingo Abbotts consumer biowearable
Sagent Pharmaceuticals Launches Zyogreen®, the First and Only Ready-to-Use Indocyanine Green Injection in the U.S.
Sagent Pharmaceuticals Sagent a leading provider of generic and specialty pharmaceuticals today announced that Zyogreen indocyanine green injection the first and only FDAapproved readytouse
Events Read more...
22 - 24
Sep 2026InsurInnovator Connect Asia
Singapore
28 - 02
Sep 2026Discovery on Target 2026
Boston, MA, USA
29 - 01
Sep 202610th IPF Summit 2026
Boston, MA, USA
29 - 01
Sep 2026Powtech Technopharm 2026
Nuremberg, Germany
30 - 01
Sep 2026Pharma Launch Excellence Summit
Hyatt Regency Boston Harbor, B...
05 - 06
Oct 2026ISPSAI France 2026
Paris, France
05 - 08
Oct 202616th World CB & CDx Summit 2026
Boston, MA, USA
12 - 14
Oct 2026Pharmaceutics 2026
Village Hotel Changi, Singapor...
LATEST NEWSRead more...
FDA Grants Breakthrough Therapy Designation to Glycomine’s GLM101 for PMM2-CDG
The US Food and Drug Administration FDA has granted Breakthrough Therapy designation to Glycomines investigational GLM for the treatment of phosphomannomutase congenital disorder of glycosylation PMMCDG
Elevar Therapeutics Announces FDA Approval of Lyrfigtu for FGFR2-Altered Cholangiocarcinoma
Elevar Therapeutics has announced that the US Food and Drug Administration FDA has approved LYRFIGTU lirafugratinib as a treatment option for patients with cholangiocarcinoma CCA with an FGFR fusion or other rearrangement
FDA grants Orphan Drug Designation to Kedrion’s QIVIGY for Stiff Person Syndrome
The US Food and Drug Administration FDA has granted Orphan Drug Designation to Kedrion Biopharmas QIVIGY immune globulin intravenous human solution for the potential treatment of Stiff Person Syndrome SPS
Pretzel Therapeutics receives FDA Fast Track Designation for PX578
Pretzel Therapeutics has received Fast Track Designation from the US Food and Drug Administration FDA for PX an investigational treatment for POLGmediated primary mitochondrial disorders also known as POLG disease
BoomRay Enters Global Licensing Agreement with Novartis for Radioligand Therapy Asset
BoomRay Pharmaceuticals has entered into an exclusive global licensing agreement with Novartis Pharma for an undisclosed preclinical radioligand therapy RLT asset
AbbVie and Iambic Collaborate to Accelerate AI-Driven Drug Discovery
AbbVie and Iambic have entered into a multiyear collaboration to accelerate the discovery and development of smallmolecule therapies with potential firstinclass and bestinclass profiles across immunology neuroscience and oncology
